20022020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Article
2002

Acute megakaryocytic leukemia in essential thrombocythemia: An unusual evolution?

Radaelli, F., Mazza, R., Curioni, E., Ciani, A., Pomati, M. & Maiolo, A. T., Aug 1 2002, In : European Journal of Haematology. 69, 2, p. 108-111 4 p.

Research output: Contribution to journalArticle

2007

CD34+ dose-driven administration of granulocyte colony-stimulating factor after high-dose chemotherapy in lymphoma patients

Todisco, E., Castagna, L., Sarina, B., Mazza, R., Magagnoli, M., Balzarotti, M., Nozza, A., Siracusano, L., Timofeeva, I., Anastasia, A., Demarco, M. & Santoro, A., Feb 2007, In : European Journal of Haematology. 78, 2, p. 111-116 6 p.

Research output: Contribution to journalArticle

2009

Allogeneic Stem Cell Transplantation Compared with Chemotherapy for Poor-Risk Hodgkin Lymphoma

Castagna, L., Sarina, B., Todisco, E., Magagnoli, M., Balzarotti, M., Bramanti, S., Mazza, R., Anastasia, A., Bacigalupo, A., Aversa, F., Soligo, D., Giordano, L. & Santoro, A., Apr 2009, In : Biology of Blood and Marrow Transplantation. 15, 4, p. 432-438 7 p.

Research output: Contribution to journalArticle

Pegfilgrastim versus filgrastim after high-dose chemotherapy and autologous peripheral blood stem cell support

Castagna, L., Bramanti, S., Levis, A., Michieli, M. G., Anastasia, A., Mazza, R., Giordano, L., Sarina, B., Todisco, E., Gregorini, A. I. & Santoro, A., Dec 11 2009, In : Annals of Oncology. 21, 7, p. 1482-1485 4 p.

Research output: Contribution to journalArticle

Treatment of refractory Hodgkin's lymphoma: A puzzle to merge

Santoro, A., Anastasia, A. & Mazza, R., 2009, In : Haematologica Meeting Reports. 3, 3, p. 129-130 2 p.

Research output: Contribution to journalArticle

2015

Brentuximab vedotin in patients with Hodgkin Lymphoma and a failed allogeneic stem cell transplantation: Results from a named patient program at four italian centers

Carlo-Stella, C., Rcci, F., Dalto, S. E., Mazza, R., Malagola, M., Patriarca, F., Viviani, S., Russo, D., Giordano, L., Castagna, L., Corradini, P. & Santoro, A., Mar 1 2015, In : The oncologist. 20, 3, p. 323-328 6 p.

Research output: Contribution to journalArticle

2016

Bendamustine in combination with gemcitabine and vinorelbine is an effective regimen as induction chemotherapy before autologous stem-cell transplantation for relapsed or refractory Hodgkin lymphoma: Final results of a multicenter phase II study

Santoro, A., Mazza, R., Pulsoni, A., Re, A., Bonfichi, M., Zilioli, V. R., Salvi, F., Merli, F., Anastasia, A., Luminari, S., Annechini, G., Gotti, M., Peli, A., Liberati, A. M., Di Renzo, N., Castagna, L., Giordano, L. & Carlo-Stella, C., Sep 20 2016, In : Journal of Clinical Oncology. 34, 27, p. 3293-3299 7 p.

Research output: Contribution to journalArticle

Bendamustine in combination with gemcitabine and vinorelbine is an effective regimen as induction chemotherapy before autologous stem-cell transplantation for relapsed or refractory Hodgkin lymphoma: Final results of a multicenter phase II study

Santoro, A., Mazza, R., Pulsoni, A., Re, A., Bonfichi, M., Zilioli, V. R., Salvi, F., Merli, F., Anastasia, A., Luminari, S., Annechini, G., Gotti, M., Peli, A., Liberati, A. M., Di Renzo, N., Castagna, L., Giordano, L. & Carlo Stella, C., Sep 20 2016, In : Journal of Clinical Oncology. 34, 27, p. 3293-3299 7 p.

Research output: Contribution to journalArticle

Bendamustine in Combination With Gemcitabine and Vinorelbine Is an Effective Regimen As Induction Chemotherapy Before Autologous Stem-Cell Transplantation for Relapsed or Refractory Hodgkin Lymphoma: Final Results of a Multicenter Phase II Study

Santoro, A., Mazza, R., Pulsoni, A., Re, A., Bonfichi, M., Zilioli, V. R., Salvi, F., Merli, F., Anastasia, A., Luminari, S., Annechini, G., Gotti, M., Peli, A., Liberati, A. M., Di Renzo, N., Castagna, L., Giordano, L. & Carlo-Stella, C., Sep 20 2016, In : Journal of Clinical Oncology. 34, 27, p. 3293-9 7 p.

Research output: Contribution to journalArticle

B-IGEV (bortezomib plus IGEV) versus IGEV before high-dose chemotherapy followed by autologous stem cell transplantation in relapsed or refractory Hodgkin lymphoma: a randomized, phase II trial of the Fondazione Italiana Linfomi (FIL)

Balzarotti, M., Brusamolino, E., Angelucci, E., Carella, A. M., Vitolo, U., Russo, E., Congiu, A., Gotti, M., Massidda, S., Botto, B., Annechini, G., Spina, M., Re, A., Zilioli, V. R., Merli, F., Salvi, F., Stelitano, C., Bonfichi, M., Rodari, M., Murru, R. & 5 others, Magagnoli, M., Anastasia, A., Mazza, R., Giordano, L. & Santoro, A., Feb 12 2016, (Accepted/In press) In : Leukemia and Lymphoma. p. 2375-2381 7 p.

Research output: Contribution to journalArticle

B-IGEV (bortezomib plus IGEV) versus IGEV before high-dose chemotherapy followed by autologous stem cell transplantation in relapsed or refractory Hodgkin lymphoma: a randomized, phase II trial of the Fondazione Italiana Linfomi (FIL)

Balzarotti, M., Brusamolino, E., Angelucci, E., Carella, A. M., Vitolo, U., Russo, E., Congiu, A., Gotti, M., Massidda, S., Botto, B., Annechini, G., Spina, M., Re, A., Zilioli, V. R., Merli, F., Salvi, F., Stelitano, C., Bonfichi, M., Rodari, M., Murru, R. & 5 others, Magagnoli, M., Anastasia, A., Mazza, R., Giordano, L. & Santoro, A., Feb 12 2016, (Accepted/In press) In : Leukemia and Lymphoma. p. 1-7 7 p.

Research output: Contribution to journalArticle

B-IGEV (bortezomib plus IGEV) versus IGEV before high-dose chemotherapy followed by autologous stem cell transplantation in relapsed or refractory Hodgkin lymphoma: a randomized, phase II trial of the Fondazione Italiana Linfomi (FIL)

Balzarotti, M., Brusamolino, E., Angelucci, E., Carella, A. M., Vitolo, U., Russo, E., Congiu, A., Gotti, M., Massidda, S., Botto, B., Annechini, G., Spina, M., Re, A., Zilioli, V. R., Merli, F., Salvi, F., Stelitano, C., Bonfichi, M., Rodari, M., Murru, R. & 5 others, Magagnoli, M., Anastasia, A., Mazza, R., Giordano, L. & Santoro, A., 2016, In : Leukemia and Lymphoma. p. 2375 2381 p.

Research output: Contribution to journalArticle

B-IGEV (bortezomib plus IGEV) versus IGEV before high-dose chemotherapy followed by autologous stem cell transplantation in relapsed or refractory Hodgkin lymphoma: a randomized, phase II trial of the Fondazione Italiana Linfomi (FIL)

Balzarotti, M., Brusamolino, E., Angelucci, E., Carella, A. M., Vitolo, U., Russo, E., Congiu, A., Gotti, M., Massidda, S., Botto, B., Annechini, G., Spina, M., Re, A., Zilioli, V. R., Merli, F., Salvi, F., Stelitano, C., Bonfichi, M., Rodari, M., Murru, R. & 5 others, Magagnoli, M., Anastasia, A., Mazza, R., Giordano, L. & Santoro, A., Oct 1 2016, In : Leukemia and Lymphoma. 57, 10, p. 2375-81 7 p.

Research output: Contribution to journalArticle

B-IGEV (bortezomib plus IGEV) versus IGEV before high-dose chemotherapy followed by autologous stem cell transplantation in relapsed or refractory Hodgkin lymphoma: a randomized, phase II trial of the Fondazione Italiana Linfomi (FIL)

Balzarotti, M., Brusamolino, E., Angelucci, E., Carella, A. M., Vitolo, U., Russo, E., Congiu, A., Gotti, M., Massidda, S., Botto, B., Annechini, G., Spina, M., Re, A., Zilioli, V. R., Merli, F., Salvi, F., Stelitano, C., Bonfichi, M., Rodari, M., Murru, R. & 5 others, Magagnoli, M., Anastasia, A., Mazza, R., Giordano, L. & Santoro, A., Feb 12 2016, (Accepted/In press) In : Leukemia and Lymphoma. p. 1-7 7 p.

Research output: Contribution to journalArticle

B-IGEV (bortezomib plus IGEV) versus IGEV before high-dose chemotherapy followed by autologous stem cell transplantation in relapsed or refractory Hodgkin lymphoma: a randomized, phase II trial of the Fondazione Italiana Linfomi (FIL)

Balzarotti, M., Brusamolino, E., Angelucci, E., Carella, A. M., Vitolo, U., Russo, E., Congiu, A., Gotti, M., Massidda, S., Botto, B., Annechini, G., Spina, M., Re, A., Zilioli, V. R., Merli, F., Salvi, F., Stelitano, C., Bonfichi, M., Rodari, M., Murru, R. & 5 others, Magagnoli, M., Anastasia, A., Mazza, R., Giordano, L. & Santoro, A., 2016, In : Leukemia and Lymphoma. 57, 10, p. 2375-2381 7 p.

Research output: Contribution to journalArticle

2017

Acute promyelocytic leukemia with a cryptic insertion of RARA into PML on chromosome 15 due to uniparental isodisomy: A case report

Venci, A., Mazza, R., Spinelli, O., Di Schiena, L. & Bettio, D., Jun 2017, In : Oncology Letters. 13, 6, p. 4180-4184 5 p.

Research output: Contribution to journalArticle

Environmental pollution and emission factors of electronic cigarettes, heat-not-burn tobacco products, and conventional cigarettes

Ruprecht, A. A., De Marco, C., Saffari, A., Pozzi, P., Mazza, R., Veronese, C., Angellotti, G., Munarini, E., Ogliari, A. C., Westerdahl, D., Hasheminassab, S., Shafer, M. M., Schauer, J. J., Repace, J., Sioutas, C. & Boffi, R., Jun 3 2017, In : Aerosol Science and Technology. 51, 6, p. 674-684 11 p.

Research output: Contribution to journalArticle

2018

Anthracycline-induced cardiotoxicity: A multicenter randomised trial comparing two strategies for guiding prevention with enalapril: The International CardioOncology Society-one trial

Cardinale, D., Ciceri, F., Latini, R., Franzosi, M. G., Sandri, M. T., Civelli, M., Cucchi, G., Menatti, E., Mangiavacchi, M., Cavina, R., Barbieri, E., Gori, S., Colombo, A., Curigliano, G., Salvatici, M., Rizzo, A., Ghisoni, F., Bianchi, A., Falci, C., Aquilina, M. & 82 others, Rocca, A., Monopoli, A., Milandri, C., Rossetti, G., Bregni, M., Sicuro, M., Malossi, A., Nassiacos, D., Verusio, C., Giordano, M., Staszewsky, L., Barlera, S., Nicolis, E. B., Magnoli, M., Masson, S., Cipolla, C. M., Maggioni, A. P., Labianca, R., Tettamanti, M., Senni, M., Finzi, A., Grosso, F., Vago, T., Gramenzi, S., Balconi, G., Bernasconi, R., Nicolis, E., Buratti, M. G., Ojeda Fernandez, M. L., Vasamì, A., Thiebat, B., Barè, C., Corzani, A., Coccolo, F., Colecchia, S., Pellegrini, C., Appio, L., Caico, I., Mesenzani, O., Campana, C., Gilardoni, M., Scognamiglio, G., Corrado, G., Battagin, D., De Rosa, F., Carpino, C., Palazzo, S., Giannessi, P. G., Zipoli, G., Pastori, P., Callegari, S., Sesenna, C., Fodor, C., Guiducci, D., Mazza, R., Turazza, F. M., Vallerio, P., Marbello, L., Sala, E., Fragasso, G., Trinca, S., Farolfi, A., Andreis, D., Lanzoni, L., Marchetti, F., Mioranza, E., Banzato, A., Re, F., Gaibazzi, N., Gullo, M., Turina, M. C., Gervasi, E., Giaroli, F., Barco, B., Bertolini, A., Sinagra, G., Aleksova, A., Guglielmi, A., Pinotti, G., Gueli, R., Mongiardi, C. & Vallini, I., 2018, In : European journal of cancer. 94, p. 126-137 12 p.

Research output: Contribution to journalArticle

Anthracycline-induced cardiotoxicity: A multicenter randomised trial comparing two strategies for guiding prevention with enalapril: The International CardioOncology Society-one trial

Investigators, ICOS-ONE. S., Cardinale, D., Ciceri, F., Latini, R., Franzosi, M. G., Sandri, M. T., Civelli, M., Cucchi, G. F., Menatti, E., Mangiavacchi, M., Cavina, R., Barbieri, E., Gori, S., Colombo, A., Curigliano, G., Salvatici, M., Rizzo, A., Ghisoni, F., Bianchi, A., Falci, C. & 31 others, Aquilina, M., Rocca, A., Monopoli, A., Milandri, C., Rossetti, G., Bregni, M., Sicuro, M., Malossi, A., Nassiacos, D., Verusio, C., Giordano, M., Staszewsky, L., Barlera, S., Masson, S., Cipolla, C. M., Maggioni, A. P., Tettamanti, M., Pellegrini, C., Scognamiglio, G., Corrado, G., De Rosa, F., Callegari, S., Fodor, C., Mazza, R., Sala, E., Fragasso, G., Farolfi, A., Andreis, D., Banzato, A., Gervasi, E. & Barco, B., May 1 2018, In : European Journal of Cancer. 94, p. 126-137 12 p.

Research output: Contribution to journalArticle

2020

Five-year results of the BEGEV salvage regimen in relapsed/refractory classical Hodgkin lymphoma

Santoro, A., Mazza, R., Pulsoni, A., Re, A., Bonfichi, M., Zilioli, V. R., Zanni, M., Merli, F., Anastasia, A., Luminari, S., Annechini, G., Gotti, M., Peli, A., Liberati, A. M., Di Renzo, N., Castagna, L., Giordano, L., Ricci, F. & Carlo-Stella, C., Jan 14 2020, In : Blood advances. 4, 1, p. 136-140 5 p.

Research output: Contribution to journalArticle

Open Access